Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Page 4 of 9« First...23456...Last »

Sanofi to buy U.S. hemophilia group Bioverativ

Paris-based Sanofi has acquired Waltham, Mass.-based Bioverativ for about $11.6 billion.

Read More »

Biotech M&A takes off: Sanofi, Celgene spend $20B

Biotech deal activity exploded with French drugmaker Sanofi and U.S.-based Celgene spending a combined total of more than $20 billion to add new products to their medicine cabinets.

Read More »

PALIO and GSW to Operate as Singular Advertising Powerhouse Under GSW Brand

PALIO will fuse with GSW to deliver customers the best of both agencies’ integrated advertising and marketing solutions.

Read More »

W2O Group Appoints Jennifer Gottlieb President

In this newly created role, Jennifer Gottlieb is responsible for three operating companies – W2O wcg, W2O twist and W2O pure.

Read More »

Teva’s asthma treatment fails late-stage studies

Teva Pharmaceutical Industries said two late-stage studies testing the company’s treatment for asthma did not meet their main goals.

Read More »

U.S. FDA Grants Priority Review for Daratumumab

The U.S. FDA granted Priority Review to daratumumab as a combination treatment for patients with newly diagnosed multiple myeloma ineligible for autologous stem cell transplant.

Read More »

Sound therapy may train brain to ignore tinnitus

A sound-emitting device worn in the ear during sleep may train the brain to ignore an annoying chronic ringing in the ears, a new study suggests.

Read More »

Personalized Medicine and Value Assessment Frameworks: Context, Considerations, and Next Steps

In this white paper, PMC contends that most value assessment frameworks could unintentionally undermine the health care community’s push toward more personalized care.

Read More »

Little-Known Life Science Hedge Fund Dethroning Ackman’s Pershing Square

Biotech investing is a volatile business as 2018 has seen a little-known hedge fund with a focus on biotech and the life sciences beat out a couple of heavy hitters, David Einhorn and Bill Ackman.

Read More »

Teva’s Job Cuts Hit 208 Philadelphia Employees

Cuts implemented by Israel-based Teva Pharmaceutical hit the shores of the United States. The company is laying off 208 people in the Philadelphia area.

Read More »

Why AstraZeneca’s New Drug Strategy Seems to be Bearing Fruit

Pharma giant AstraZeneca has seen a fourfold increase in research productivity following a narrowing of disease focus and cuts in laboratory and staff over the past seven years, Reuters reported.

Read More »

U.S. health agency to issue religious objection regulations

The HHS is issuing new regulations aimed at protecting healthcare workers’ civil rights based on religious and conscience objections.

Read More »

Lynparza Receives Approval in Japan for Treating Advanced Ovarian Cancer

AstraZeneca and Merck announced that the Japanese Ministry of Health, Labour and Welfare approved Lynparza (olaparib) tablets (300mg twice daily) for use as a maintenance therapy for patients with platinum-sensitive relapsed ovarian cancer, regardless of their BRCA mutation status, who responded to their last platinum-based chemotherapy.

Read More »

FDA: New drug compounding priorities

The FDA head is preparing a new, more restrictive policy targeting which drugs compounding pharmacies can produce that do not go through the regulatory agency’s approval process.

Read More »

European Commission Approves Mvasi For Treating Certain Types Of Cancer

Amgen Inc. and Allergan plc. announced that the European Commission granted marketing authorization for Mvasi (biosimilar bevacizumab).

Read More »

Celgene to Create Biopharma Incubator on New Jersey R&D Site

Fresh off its $7 billion acquisition of San Diego-based Impact Biomedicines and its JAK inhibitor program targeting myelofibrosis, Celgene is planning to open a biopharma incubator on its corporate campus in New Jersey.

Read More »

5 Healthcare Systems Launching Generics Company

The U.S. Department of Veterans Affairs and Intermountain Healthcare, Ascension, SSM Health and Trinity Health are forming a not-for-profit generic drug company.

Read More »

Homology Inks Deal for New Massachusetts HQ

Backed by financing from a collaboration with Novartis and an $83 million financing round, Homology Medicines is moving to a new facility with more than triple the space of its headquarters.

Read More »

Toothpaste ingredient could fight malaria, research shows

Research carried out in part by an artificially intelligent ‘robot scientist’ found that a common ingredient of toothpaste could be developed to fight drug-resistant strains of malaria.

Read More »

U.S. court invalidates patent on J&J cancer drug Zytiga

A U.S. administrative court invalidated a Johnson & Johnson patent on its blockbuster prostate cancer drug Zytiga, bringing rivals closer to selling generic versions.

Read More »

Page 4 of 9« First...23456...Last »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom